Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • brentonmar
    Junior Member
    • Jan 2012
    • 1

    #1

    Quantifying allele fraction of small to medium deletions in amplication sequencing

    Hi all,

    I would like to use MiSeq amplicon sequencing to detect the clonal outgrowth of cells harboring small to medium sized deletions (1bp to 160bp) in specific genes generated using CRISPR technology (which makes random sized deletions at specific loci matching a DNA template).

    I've used BWA/Varscan in the past to quantify the allele fraction of small (1-3bp) deletions. I've also used pindel to qualitatively identify larger deletions, but I'm unsure if one can quantatively estimate the allele fraction of deletion using pindel or other tools. Has anyone tried this or have any advice?

    Thanks!
    -Brenton
  • chrisamiller
    Junior Member
    • Jun 2008
    • 7

    #2
    It's a challenging issue that usually requires several steps:

    1) local assembly to identify the exact sequence of the large indel
    2) creation of a contig containing that sequence
    3) competitive realignment to discover reads that span the breakpoint, but couldn't be mapped previously

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    67 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    47 views
    0 reactions
    Last Post SEQadmin2  
    Working...